O/T: Didn't want to start a new thread, but ELTP has been gaining traction for the last two weeks and yesterday added $0.05 closing at .44. Today it's up again against the markets down. They have opiod abuse deterant technologies they are expected to submit an NDA before year end. They also own a series of smaller drugs they are commercializing. I started buying them after their last explosion to $0.94 and am now profitable on a fairly substantial # shares. So many things I like about the Company, check it out.
PS I added another 1,000 shares of ATRS today, also GALE at 2.36.
when I posted last week a link to an article "No Effect of Hormones on Postpartum Relapse Rate in MS", I got couple of angry replies.
So some folks do not want to hear anything negative to their investments.
It is valid for any stock ....
Yes,Whogo70 you did say you were not comfortable with the data ,
I was hoping it was the 1% that your wrong .:-)
Should have known when SM shorted 8k shares , I will never
doubt you again SIR WHOGO,you DA MAN !
Why the massive drop after the preliminary data report? Granted, it's an investigator-initiated phase 2 trial so it means nothing in terms of potential drug approvals, but I would have expected that it would drive the price up. It's certainly justification for a phase 3 approval trial (assuming no increased cancer/heart disease risks emerge) - or good reason to license out to another company for development. Seems like good news to me...